Ovarian Tumor

This page contains recent news articles, when available, and an overview of Ovarian Tumor but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Ovarian Tumor

RHS November Program: The Life of Dr. Ephraim McDowell, Pioneer Surgeon  -  ‎Nov 20, 2009‎
Rockbridge WeeklyDr. Ephraim McDowell removed a twenty-two-and-one-half-pound ovarian tumor from 46-year-old Jane Todd Crawford, who had grown up near Whistle Creek. ...

Cancer was woman's trip of hope, peace  -  ‎Nov 6, 2009‎
Savage PacerIt was during the surgery that her parents, Mary Lou and Richard Pederson, were hit with news that the 6.5 pound ovarian tumor was cancerous. ...

Nanoparticles for gene therapy improve  -  ‎Nov 7, 2009‎
Media Newswire (press release)This summer, the two laboratories reported that the nanoparticle-delivered gene therapy successfully suppressed ovarian tumor growth in mice. ...

Bowling Green: Federal Education Grant Funds WKU Super Computer  -  ‎Nov 11, 2009‎
Lane Report...“When combined with other clinical information, the OVA1 biomarker panel can help assess the likelihood of malignancy of an ovarian tumor before surgery and ...

International healer to talk about "Christ love"  -  ‎Nov 10, 2009‎
Redlands Daily FactsGreenwood, a medical nurse and international lecturer, said prayer power cured her after a non-cancerous ovarian tumor was removed. ...

Co-workers support family in need  -  ‎Nov 1, 2009‎
Northwest HeraldHer mom has been in and out of the hospital for the past three years because of health issues that started with an ovarian tumor. ...

'Suicide' Genes Help Slow Ovarian Tumor Growth in Mice  -  ‎Jul 30, 2009‎
U.S. News & World ReportTHURSDAY, July 30 (HealthDay News) -- Treatment with "suicide" genes slowed ovarian tumor growth in mice and may one day offer a way to treat late-stage

Development of targeted therapy for ovarian cancer mediated by a ...  -  ‎Aug 6, 2009‎
7thSpace Interactive (press release)Hence, we developed a new therapy strategy to target the expression of diphtheria toxin gene under the control of H19 regulatory sequences in ovarian tumor

CytRx Provides Result Of Cancer Drug Candidate Trials  -  ‎Jul 29, 2009‎
Pharmaceutical Business ReviewIn the animal study, ten million human A2780 ovarian tumor cells from cell culture were transplanted under the skin in the left flank region of 18 mice,

Therapy Inhibits Ovarian Cancer in Mice  -  ‎Aug 4, 2009‎
MedPage TodayTherapy targeting a protein overexpressed in ovarian cancer inhibited tumor growth by as much as 98% in a

Primary ovarian leiomyoma associated with endometriotic cyst ...  -  ‎Jul 30, 2009‎
7thSpace Interactive (press release)Upon laparotomy, there was a solid, oval left-sided ovarian tumor located behind the uterus. The tumor was sent to the pathology department.

Tiny Early-Stage Ovarian Tumors Define Early Detection Challenge  -  ‎Jul 27, 2009‎
Howard Hughes Medical Institute...“Our work provides a picture of the early events in the life of an ovarian tumor, before the patient knows it's there,�? says Howard Hughes Medical Institute

Vermillion Deadline for Chapter 11 Reorganization Plan Pushed Back ...  -  ‎Aug 5, 2009‎
GenomeWeb Daily News..."However, [Vermillion's] future business prospects and success depends on the [US] Food and Drug Administration's approval process of the ovarian tumor

HRT increases odds of ovarian cancer: Study  -  ‎Jul 15, 2009‎
TheMedGuru...of ovarian cancer including 2681 cases of epithelial ovarian cancers, the most common type of ovarian tumor infecting the outer lining of the ovaries.

PIK3CA alterations in Middle Eastern Ovarian Cancers  -  ‎Jul 28, 2009‎
7thSpace Interactive (press release)KRAS, BRAF genes, which suggests that each of these alterations may individually be sufficient to drive ovarian tumor pathogenesis independently.

Son of Italian saint is coming next month to St. Paul  -  ‎Jul 16, 2009‎
The Catholic Spirit...and general practitioner, St. Gianna was pregnant with the couple's fourth child when doctors discovered an ovarian tumor that required surgery.

RNAi Processing Machinery Expression Predicts Ovarian Cancer ...  -  Dec 18, 2008
GenomeWeb News,Because small RNA processing is hampered in many of the ovarian tumor samples, treatments that require such processing likely won’t be effective.

Morphotek ® , Inc. Announces Initiation of Farletuzumab Phase II ...  -  Dec 2, 2008
Business Wire (press release),...from a Phase I trial of farletuzumab in patients with PR ovarian cancer as well as data derived from preclinical models using PR ovarian tumor cells.

Possible way to treat ovarian cancer reported  -  Dec 15, 2008
Reuters UK,The researchers found that blocking MYC inhibited ovarian tumor cell proliferation in MYC-amplified cell lines, and silencing all related MYC 'isoforms' led

Doctors didn’t steal kidney, says hospital  -  Dec 5, 2008
Thanh Nien Daily,A southern metro-based obstetrics hospital has denied a patient’s allegations that doctors took out her kidney during an ovarian tumor surgery, according to

Aurora kinase inhibitors synergize with paclitaxel to induce ...  -  Dec 11, 2008
7thSpace Interactive (press release),Methods: We used expression profiling of ovarian tumor samples to determine the most significantly overexpressed genes. In this study we sought to determine

Woman retracts complaints of kidney theft after test  -  Dec 12, 2008
Thanh Nien Daily,The test results showed she had a large ovarian tumor, while she was not suffering from kidney stones. However, when she had a check-up at the medical

Independent Data Monitoring Committee Recommends Marshall Edwards ...  -  Nov 12, 2008
CNNMoney.comThe Independent Data Monitoring Committee (IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor REsponse (OVATURE) Trial,

Cancer center to join gene project  -  Oct 24, 2008
The News Journal,The Graham center will collect 100 lung tumor specimens, 20 brain tumor specimens and 20 ovarian tumor specimens a year for each of the next four years.

Vermillion Announces Third Quarter 2008 Financial Results and ...  -  Nov 14, 2008
SYS-CON Media,Ovarian Cancer Diagnostic Program: -- Vermillion's OVA1(TM) 510(k) pre-market notification application for its ovarian tumor triage test is currently

Independent Data Monitoring Committee Recommends Marshall Edwards ...  -  Nov 13, 2008
MarketWatch...(IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor REsponse (OVATURE) Trial, yesterday recommended continuation of the study.

Fibroma with minor sex cord elements: a case report and review  -  Oct 23, 2008
7thSpace Interactive (press release),Histologically, the ovarian tumor was a fibroma with minor sex cord elements. Conclusion: Clinical manifestations of a hyperestrogenic state in

Judge candidates have experience on other side of the bench  -  Oct 28, 2008
The Herald-Times (subscription),...“I had an ovarian tumor. I have partner benefits through IU, but the hospital refused acceptance of those benefits, saying it was a pre-existing condition.

MSHL: Independent Data Monitoring Committee Recommends Trial ...  -  Nov 12, 2008
Trading Markets (press release),The Independent Data Monitoring Committee (IDMC) has recommended continuation of Marshall Edwards, Inc.'s (MSHL) Phase III OVArian TUmor REsponse (OVATURE)

OXiGENE reports positive data from ongoing mid-stage ZYBRESTAT ...  -  Oct 27, 2008
RTT News,...(RTTNews) - Monday, biopharmaceutical company OXiGENE, Inc. (OXGN: News ) announced positive interim results from an ongoing phase 2 study of ZYBRESTAT in

Vermillion to Host Live Roundtable Discussion With Principal ...  -  12 Jul 2008
FOXBusinessVermillion's ovarian tumor triage test utilizes a panel of biomarkers designed to help identify women at high risk of having cancer so that they can be

Vermillion seeks FDA approval of ovarian tumor triage test  -  Jun 25, 2008
Bizjournals.com,Vermillion Inc. said Wednesday it has applied to the US Food & Drug Administration for approval to market its ovarian tumor triage test.

Vermillion Files Pre-Marketing Application to FDA for Ovarian ...  -  Jun 26, 2008
RedOrbit,Vermillion has submitted a 510(k) pre-market notification application to the FDA requesting regulatory clearance of its ovarian tumor triage test known as

Cancer can't keep her from leading the class  -  Jun 25, 2008
The Oregonian - OregonLive.com,In the middle of the night, Myers and her family found out she had a large ovarian tumor. Surgery two days later confirmed it was cancerous.

Clinical Proteomics Advances as Vermillion, LabCorp, Correlogic ...  -  Jun 26, 2008
Proteo Monitor,Two days later, Vermillion announced that it had filed its OVA1 ovarian tumor triage test with the US Food and Drug Administration for 510(k) pre-market

VRML: Submits 510(k) Application to FDA for OVA1 Ovarian Tumor ...  -  Jun 25, 2008
Trading Markets (press release),Vermillion, Inc. (VRML) has submitted a 510(k) pre-market notification application to the FDA requesting regulatory clearance of its Ovarian Tumor Triage

FivePrime, Pfizer, Lab901, Seegene, Roche, Proventys, Vermillion ...  -  21 May 2008
Pharmacogenomics Reporter (subscription),...based firm is developing molecular diagnostic tests and expects to file its ovarian tumor triage test, called OVA1, with the US Food and Drug Administration

Vermillion Cuts Q1 Loss, Prepares to File Ovarian Tumor Test with FDA  -  May 15, 2008
GenomeWeb News (subscription),...based firm is developing molecular diagnostic tests and expects to file its ovarian tumor triage test, called OVA1, with the US Food and Drug Administration

New Tests Could Help Detect Ovarian Cancer Earlier  -  May 2, 2008
NBC 4.com,Currently, if a woman develops an ovarian tumor, there is no way for doctors to know if it's cancerous. Vermillion has developed a blood test that can

Extended Accrual Time and Decreased Sample Size for OVATURE, a ...  -  May 9, 2008
CNNMoney.comThe accrual time for the OVArian TUmor REsponse (OVATURE) clinical study, a Phase III study of the investigational chemosensitizing drug, phenoxodiol,

Vermillion Announces First Quarter 2008 Financial Results and ...  -  May 15, 2008
MSN MoneyThe Company plans to finalize its clinical study examining the Ovarian Tumor Triage Test, now named OVA1(TM), and submit OVA1 to the US Food and Drug

Health & Fitness : TriMark Publications Announces TriMark Cancer ...  -  Apr 28, 2008
Prudent Press Agency (press release),Novel biomarkers for ovarian tumor triage and peripheral arterial disease. The clinical dilemma facing non-invasive biomarker assays.

Early Warning Sought For Ovarian Cancer  -  May 11, 2008
RedOrbit,Even after her surgery, Robertson continues to get regular blood tests for CA-125, a biomarker that can sometimes detect the presence of an ovarian tumor

Vermillion reports positive results for ovarian tumor test  -  Mar 20, 2008
Bizjournals.com,Vermillion Inc. said Thursday a clinical trial evaluating its ovarian tumor triage test showed early promise for separating women with pelvic tumors into

Vermillion ovarian tumor test does well in clinical trial  -  Mar 20, 2008
Bizjournals.com,The Fremont company's test, called the ovarian tumor triage test, is meant to improve survival rates for women diagnosed with such tumors by putting them

Vermillion Announces Positive Results From Clinical Trial of ...  -  Mar 20, 2008
Earthtimes,The Ovarian Tumor Triage Test provides information that may help improve outcomes for the hundreds of thousands of women in the United States who annually

Vermillion to File Ovarian Tumor Triage Panel Within Next Few Months  -  Mar 20, 2008
GenomeWeb News (subscription),By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Vermillion said today that its Ovarian Tumor Triage Test met its primary endpoints in a clinical

Hanoi surgeons extract 27kg ovarian tumor  -  Mar 13, 2008
Thanh Nien Daily,Doctors at the Hanoi Cancer Hospital removed a 27-kilogram ovarian tumor from a woman from the northern province of Cao Bang Wednesday.

Roswell Park Cancer Institute Receives Grant To Develop Vaccine ...  -  Mar 17, 2008
Medical News Today (press release),...tryptophan, to poison the subset of "bad" CD4 lymphocytes and thereby unleash tumor-specific CD8 cells to respond and kill ovarian tumor cells.

Vermillion's Biomarkers Prove Beneficial in Identifying Women With ...  -  Mar 10, 2008
PR Newswire (press release),Further Evidence Supporting Ovarian Tumor Triage Test (Poster 135) A clinical study examining Vermillion's marker panel for ovarian cancer provided

Market Report -- In Play (VRML)  -  Mar 20, 2008
MSN MoneyVermillion announces "Positive Results" from clinical trial of ovarian tumor triage test; Study meets primary endpoints Co announces preliminary results

News From The Journal Of Clinical Investigation March 13, 2008  -  Mar 14, 2008
Medical News Today (press release),Determining the molecules and mechanisms involved in the attachment of ovarian tumor cells to these sites is therefore critical for the development of

Phenoxodiol Trials Highlighted at Ovarian Cancer Action ...  -  Mar 10, 2008
CNNMoney.comThe OVArian TUmor REponse (OVATURE) trial is a major multi-center multinational Phase III clinical trial of orally-administered phenoxodiol in combination

Vermillion Receives Award From the Society of Gynecologic Oncologists  -  Feb 28, 2008
Earthtimes,The abstract, which demonstrated that the Company's Ovarian Tumor Triage Test correctly identified 84 percent of ovarian cancer cases compared to only 33

Liposomal Doxorubicin in Suspected Ovarian Carcinoma Patient  -  Mar 5, 2008
Medscape (subscription)She had a suspected ovarian tumor, most likely a carcinoma. Because of age, poor general condition, and high blood pressure, she could not be operated on by

Vermillion Reports Success of Ovarian Cancer Biomarker Panel  -  Mar 11, 2008
Genetic Engineering News (press release),This model, the ovarian tumor triage test, was then used in a prospectively collected cohort of 709 women from Rigshospitalet in Copenhagen.

Ovarian cancer soon to be treatable  -  Mar 8, 2008
PRESS TV,By Patricia Khashayar, MD., Press TV, Tehran Dr Anil Sood is the Professor and Director of Ovarian Cancer Research in the Departments of Gynecologic

New Ovarian Cancer Treatment?  -  Feb 28, 2008
Ivanhoe,Scientists say the protein interleukin-8 (IL-8) promotes ovarian tumor growth. In a recent study, researchers found 42.16 percent of ovarian tumors had a

Vermillion's Q4 Loss Widens, Revenues Fall in Anticipation of Dx ...  -  Mar 5, 2008
GenomeWeb News (subscription),Vermillion said it expects to report top-line data from an ovarian tumor triage clinical trial later this quarter and submit its ovarian cancer diagnostic

Pettem: Maxwell immortalized animals in life-like settings  -  Mar 7, 2008
Daily Camera,Five years later, in 1881, Maxwell had an ovarian tumor and died in New Jersey, in her daughter's arms. The "Colorado Huntress," as Maxwell was called,

Background information on Ovarian Tumor [When available]

An ovarian cyst is any collection of fluid within the ovary. Some of these, called functional cysts, are part of the normal process of menstruation. Any ovarian follicle that is larger than about 2 centimeters is termed an ovarian cyst. Specific types of cyst include graafian follicles (which may rupture at mid-cycle and cause mittelschmerz) or corpus luteum cysts (which may rupture about the time of menstruation, and take up to three months to disappear entirely). Other cysts are pathological, such as those found in polycystic ovary syndrome, or those associated with tumors.

Search the web for more resources on Ovarian Tumor

Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

The Cancer News Network


Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

We will do our best to accommodate your request.